Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
78.84
-1.17 (-1.46%)
At close: Aug 14, 2026, 4:00 PM EDT
78.91
+0.07 (0.09%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Disc Medicine Employees
Disc Medicine had 165 employees as of June 30, 2026. The number of employees increased by 40 or 32.00% compared to the same quarter last year.
Employees
165
Change
40
Growth
32.00%
Revenue / Employee
n/a
Profits / Employee
-$1,490,230
Market Cap
3.03B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 165 | 40 | 32.00% | 165 | 0 |
| Mar 31, 2026 | 154 | 60 | 63.83% | 154 | 0 |
| Dec 31, 2025 | 155 | 71 | 84.52% | 155 | 0 |
| Sep 30, 2025 | 142 | 60 | 73.17% | 142 | 0 |
| Jun 30, 2025 | 125 | 47 | 60.26% | 125 | 0 |
| Mar 31, 2025 | 94 | 16 | 20.51% | 94 | 0 |
| Dec 31, 2024 | 84 | 10 | 13.51% | 84 | 0 |
| Sep 30, 2024 | 82 | 22 | 36.67% | 82 | 0 |
| Jun 30, 2024 | 78 | 23 | 41.82% | 78 | 0 |
| Mar 31, 2024 | 78 | 27 | 52.94% | 78 | 0 |
| Dec 31, 2023 | 74 | 28 | 60.87% | 74 | 0 |
| Sep 30, 2023 | 60 | 22 | 57.89% | 60 | 0 |
| Jun 30, 2023 | 55 | 17 | 44.74% | 55 | 0 |
| Mar 31, 2023 | 51 | 13 | 34.21% | 51 | 0 |
| Dec 31, 2022 | 46 | - | - | 46 | 0 |
| Jun 30, 2022 | 38 | - | - | 37 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Iovance Biotherapeutics | 975 |
| Tarsus Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Nurix Therapeutics | 317 |
| Immunome | 247 |
| Alumis | 239 |
| uniQure | 221 |
IRON News
- 16 days ago - Disc Medicine reports Q2 EPS ($1.54), consensus ($1.77) - TheFly
- 16 days ago - Disc Medicine Slides: Corporate presentation - Filings
- 16 days ago - Disc Medicine Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 16 days ago - Disc Medicine Earnings release: Q2 2026 - Filings
- 16 days ago - Disc Medicine Quarterly report: Q2 2026 - Filings
- 2 months ago - Disc Medicine Transcript: AGM 2026 - Transcripts
- 2 months ago - Disc Medicine price target raised to $85 from $80 at Morgan Stanley - TheFly
- 2 months ago - Disc Medicine Transcript: Study update - Transcripts